Notable companies
The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), Abbott Laboratories (NYSE:ABT), Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG), Elevance Health (NYSE:ELV), Boston Scientific Corp (NYSE:BSX), McKesson Corp (NYSE:MCK).
Industry description
The investment seeks to maximize total return.
Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.
Market Cap
The average market capitalization across the iShares Health Innovation Active ETF ETF is 33.16B. The market cap for tickers in the group ranges from 62.92M to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is CABA at 62.92M.
High and low price notable news
The average weekly price growth across all stocks in the iShares Health Innovation Active ETF ETF was -2%. For the same ETF, the average monthly price growth was -6%, and the average quarterly price growth was -7%. MCK experienced the highest price growth at 5%, while PCVX experienced the biggest fall at -51%.
Volume
The average weekly volume growth across all stocks in the iShares Health Innovation Active ETF ETF was 12%. For the same stocks of the ETF, the average monthly volume growth was -9% and the average quarterly volume growth was 51%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 60
P/E Growth Rating: 74
Price Growth Rating: 69
SMR Rating: 79
Profit Risk Rating: 75
Seasonality Score: -2 (-100 ... +100)